Year: 2021

Aspo PlcPress ReleaseNovember 22, 2021, at 9.45 a.m. Invitation to Aspo’s Capital Markets Day on December 1, 2021 Aspo invites investors, analysts, and media representatives to attend its Capital Markets Day (CMD) which will be held as previously announced on December 1, 2021. The event starts at 1 p.m. and ends no later than 3.30 p.m. During the event, the Group’s strategy and the current state and outlook of the businesses will all be discussed in detail. Presentations are given by the Group CEO Rolf Jansson and the Managing Directors of Aspo’s businesses Matti-Mikael Koskinen, Mikko Pasanen and Heli Arantola. The presentations are given in Finnish and the materials are in English. The event can be followed by a live webcast at: https://aspo.videosync.fi/cmd-2021. Institutional investors, analysts and media representatives are also welcomed...

— Third Quarter Total Volume of e-scooter sales up 58.3% year over year — Third Quarter Revenues of RMB 1,226.4 million, up 37.1% year over year — Third Quarter Net Income of RMB 91.7 million, compared with RMB 80.0 million in the same period of last year BEIJING, Nov. 22, 2021 (GLOBE NEWSWIRE) — Niu Technologies (“NIU”, or “the Company”) (NASDAQ: NIU), the world’s leading provider of smart urban mobility solutions, today announced its financial results for the third quarter 2021. Third Quarter 2021 Financial HighlightsRevenues were RMB 1,226.4 million, an increase of 37.1% year over year Gross margin was 20.0%, compared with 20.9% in the third quarter of last year Net income was RMB 91.7 million, an increase of 14.6% compared with RMB 80.0 million in the third quarter of last year Adjusted net income (non-GAAP)1...

Company Announcement, Inside information, Helsinki, 22.11.2021 at 9 AM (EET) Nexstim Agrees on a Strategic Investment into a Management Services Organisation of a California Based Clinic Providing Treatments for Depression Patients Nexstim Plc’s (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”) US subsidiary Nexstim, Inc. has signed an agreement regarding a strategic alliance with and a minority ownership in PNC Management Services, LLC. Nexstim, Inc. will fund the transaction from cash on hand. The transaction price is estimated to be approximately EUR 0.5 million. The closing of this transaction is subject to customary closing conditions and is estimated to be finalised during the coming weeks. PNC Management Services, LLC was organized to provide management, consulting, administrative, and other support services...

Fingerprint Cards AB (publ) today announced that the company expects Group revenues for the full year 2022 to be in the range of SEK 1,600-2,000 million, based on the exchange rate SEK/USD 8.70, and that the EBITDA margin is expected to be in the range of 14-18 percent for the fourth quarter of 2022. “At the same time as demand for our products remains healthy in the mobile industry, our revenue streams are now being diversified at a higher pace than previously, into areas with attractive margins. The good sales growth in 2022 is expected to be generated mainly in the areas of Mobile, PC and Access. This is despite the fact that we expect the current semiconductor shortage in the world to persist throughout 2022. When access to semiconductors and production capacity is normalized, there is additional scope for significant sales increases....

FDA Accepts NDA for Linzagolix for the Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids   Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland November 22, 2021 – Obseva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today announced that the New Drug Application (NDA) for linzagolix for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women has been accepted for review by the United States Food and Drug Administration (FDA). The submission is based on data from the two Phase 3 PRIMROSE trials. Linzagolix has a differentiated profile and if approved, would be the first and only GnRH receptor antagonist with flexible dosing options for uterine...

Ericsson enters into agreement for USD 6.2 billion cash offer to acquire Vonage, a global provider of cloud-based communications, with unanimous approval of the Vonage Board of DirectorsAcquisition underlines Ericsson strategy to expand its presence in wireless enterprise and broaden its global offerings Robust performance and growth prospects are built on the Vonage Communications Platform (VCP), which delivers about 80% of Vonage’s total revenues and serves more than one million registered developers globally Transaction expected to be accretive to Ericsson’s EPS (excluding non-cash amortization impacts) and free cash flow before M&A from 2024 onwards Closing expected in the first half of 2022, subject to Vonage shareholder approval, regulatory approvals, and other customary conditionsHOLMDEL, N.J., Nov. 22, 2021 (GLOBE NEWSWIRE)...